Statin use appears to be associated with susceptibility or the progression of interstitial lung disease (ILD) in current and former smokers, according to a study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. Although some investigations have indicated that statins may be beneficial in treating fibrotic lung disease, other studies have indicated that statins might contribute to the progression of pulmonary fibrosis, by improving excretion of inflammasome-regulated cytokines... (Source: Health News from Medical News Today)

Respiration (DOI:10.1159/000334320) (Source: Respiration)

(MedPage Today) -- Smokers are no more likely to give up cigarettes for good by using nicotine replacement products such as patches and gum than if they did not use those quit-smoking aids, a prospective cohort study showed. (Source: MedPage Today Pulmonary)

SUMMARYThe effect of antisecretory treatment on extraesophageal symptoms of gastroesophageal reflux disease was evaluated. Seventy‐eight children presenting with typical and extraesophageal symptoms of gastroesophageal reflux disease underwent a multichannel intraluminal impedance and pH monitoring (MII/pH). Children with a positive MII/pH were randomly treated with proton pump inhibitors (PPIs) or histamine H2‐receptor antagonists (H2RAs) during 3 months. At the end of the treatment period, all patients were recalled. A second treatment period of 3 months was given to those patients who were not symptom‐free after 3 months. Thirty‐five of the forty‐one (85.4%) children with a pathologic MII/pH presented with extraesophageal symptoms and were treated with PPIs (omeprazole; n:19) ...